Epidermolysis bullosa: Directions for future research and new challenges for treatment

Archives of Dermatological Research, Supplement

Volumn 295, Issue 1, 2003, Pages

  Sawamura, Daisuke ^a   McMillan, James R ^a   Akiyama, Masashi ^a   Shimizu, Hiroshi ^a  

^a HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Classification; Gene therapy; Prenatal diagnosis

Indexed keywords

KERATIN; PLECTIN; ALPHA6BETA4 INTEGRIN; BULLOUS PEMPHIGOID ANTIGEN 1; COLLAGEN TYPE 7;

ARTICLE; DISEASE CLASSIFICATION; EPIDERMOLYSIS BULLOSA; EPIDERMOLYSIS BULLOSA DYSTROPHICA; EPIDERMOLYSIS BULLOSA SIMPLEX; GENE MUTATION; GENE THERAPY; HUMAN; MEDICAL RESEARCH; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; AMNION; ATRESIA; FIBER; GENE TRANSFER; GENETIC HETEROGENEITY; NAIL DYSTROPHY; PATHOGENESIS; PYLORUS; SKIN AUTOGRAFT; SKIN BIOPSY; SKIN DISEASE; SKIN FRAGILITY; SQUAMOUS CELL CARCINOMA; STEM CELL;

EID: 0038636516     PISSN: 09441948     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-002-0370-7     Document Type: Article

References (81)

1. Fine JD, Bauer EA, Briggaman RA, Carter DM, Eady RA, Esterly NB, Holbrook KA, Hurwitz S, Johnson L, Lin A, et al (1991) Revised clinical and laboratory criteria for subtypes of inherited epidermolysis bullosa. A consensus report by the Subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 24:119-135
2. Uitto J, Pulkkinen L (2000) The genodermatoses: candidate diseases for gene therapy. Hum Gene Ther 11:2267-2275
3. Fine JD, Eady RA, Bauer EA, Briggaman RA, Bruckner-Tuderman L, Christiano A, Heagerty A, Hintner H, Jonkman MF, McGrath J, McGuire J, Moshell A, Shimizu H, Tadini G, Uitto J (2000) Revised classification system for inherited epidermolysis bullosa: report of the Second International Consensus Meeting on Diagnosis and Classification of Epidermolysis Bullosa. J Am Acad Dermatol 42:1051-1066
4. Eady RA (2001) Epidermolysis bullosa: scientific advances and therapeutic challenges. J Dermatol 28:638-640
5. Uitto J, Pulkkinen L (2001) Molecular genetics of heritable blistering disorders. Arch Dermatol 137:1458-1461
6. Ashton GH, Sorelli P, Mellerio JE, Keane FM, Eady RA, McGrath JA (2001) Alpha 6 beta 4 integrin abnormalities in junctional epidermolysis bullosa with pyloric atresia. Br J Dermatol 144:408-414
7. Gache Y, Allegra M, Bodemer C, Pisani-Spadafora A, de Prost Y, Ortonne JP, Meneguzzi G (2001) Genetic bases of severe junctional epidermolysis bullosa presenting spontaneous amelioration with aging. Hum Mol Genet 10:2453-2461
8. Irvine AD, McLean WH (1999) Human keratin diseases: the increasing spectrum of disease and subtlety of the phenotype-genotype correlation. Br J Dermatol 140:815-828
9. Sorensen CB, Ladekjaer-Mikkelsen AS, Andresen BS, Brandrup F, Veien NK, Buus SK, Anton-Lamprecht I, Kruse TA, Jensen PK, Eiberg H, Bolund L, Gregersen N (1999) Identification of novel and known mutations in the genes for keratin 5 and 14 in Danish patients with epidermolysis bullosa simplex: correlation between genotype and phenotype. J Invest Dermatol 112: 184-190
10. Shemanko CS, Mellerio JE, Tidman MJ, Lane EB, Eady RA (1998) Severe palmo-plantar hyperkeratosis in Dowling-Meara epidermolysis bullosa simplex caused by a mutation in the keratin 14 gene (KRT14). J Invest Dermatol 111:893-895
11. Sorensen CB, Ladekjaer-Mikkelsen AS, Andresen BS, Brandrup F, Veien NK, Buus SK, Anton-Lamprecht I, Kruse T, Jensen PK, Eiberg H, Bolund L, Gregersen N (2000) Epidermolysis bullosa simplex: genotype-phenotype correlation in Danish patients (in Danish). Ugeskr Laeger 162:1873-1876
12. Yasukawa K, Sawamura D, McMillan JR, Nakamura H, Shimizu H (2002) Dominant and recessive compound heterozygous mutations in Epidermolysis Bullosa simplex demonstrate the role of the stutter region in keratin intermediate filament assembly. J Biol Chem 277:23670-23674
13. Shimizu H, Takizawa Y, Pulkkinen L, Murata S, Kawai M, Hachisuka H, Udono M, Uitto J, Nishikawa T (1999) Epidermolysis bullosa simplex associated with muscular dystrophy: phenotype-genotype correlations and review of the literature. J Am Acad Dermatol 41:950-956
14. Smith FD, Eady RAJ, Leigh IM, McMillan JR, Rugg EL, Kelsell DP, Bryant SP, Spurr NK, Geddes JF, Kirtschig G, Milana G, de Bono AG, Owaribe K, Wiche G, Pulkkinen L, Uitto J, McLean WHI, Lane EB (1996) Plectin deficiency: hereditary basis for muscular dystrophy with epidermolysis bullosa. Nat Genet 13:450-457
15. McLean WH, Pulkkinen L, Smith FJ, Rugg EL, Lane EB, Bullrich F, Burgeson RE, Amano S, Hudson DL, Owaribe K, McGrath JA, McMillan JR, Eady RA, Leigh IM, Christiano AM, Uitto J (1996) Loss of plectin causes epidermolysis bullosa with muscular dystrophy: cDNA cloning and genomic organization. Genes Dev 10:1724-1735
16. Mellerio JE, Smith FJ, McMillan JR, McLean WH, McGrath JA, Morrison GA, Tierney P, Albert DM, Wiche G, Leigh IM, Geddes JF, Lane EB, Uitto J, Eady RA (1997) Recessive epidermolysis bullosa simplex associated with plectin mutations: infantile respiratory complications in two unrelated cases. Br J Dermatol 137:898-906
17. Fontao L, Geerts D, Kuikman I, Koster J, Kramer D, Sonnenberg A (2001) The interaction of plectin with actin: evidence for cross-linking of actin filaments by dimerization of the actin-binding domain of plectin. J Cell Sci 114:2065-2076
18. Fuchs P, Zorer M, Rezniczek GA, Spazierer D, Oehler S, Castanon MJ, Hauptmann R, Wiche G (1999) Unusual 5′ transcript complexity of plectin isoforms: novel tissue-specific exons modulate actin binding activity. Hum Mol Genet 8:2461-2472
19. Wiche G (1998) Role of plectin in cytoskeletal organization and dynamics. J Cell Sci 111:2477-2486
20. Pulkkinen L, Uitto J (1999) Mutation analysis and molecular genetics of epidermolysis bullosa. Matrix Biol 18:29-42
21. Uitto J, Pulkkinen L, Smith FJ, McLean WH (1996) Plectin and human genetic disorders of the skin and muscle. The paradigm of epidermolysis bullosa with muscular dystrophy. Exp Dermatol 5:237-246
22. Shimizu H (1998) New insights into the immunoultrastructural organization of cutaneous basement membrane zone molecules. Exp Dermatol 7:303-313
23. Leung CL, Liem RK, Parry DA, Green KJ (2001) The plakin family. J Cell Sci 114:3409-3410
24. Green KL, Jones JCR (1996) Desmosomes and hemidesmosomes: structure and function of molecular components. FASEB J 10:872-880
25. Guo L, Degenstein L, Dowling J, Yu QC, Wollmann R, Perman B, Fuchs E (1995) Gene targeting of BPAG1: abnormalities in mechanical strength and cell migration in stratified epithelia and neurologic degeneration. Cell 81:233-243
26. Houseweart MK, Cleveland DW (1999) Cytoskeletal linkers: new MAPs for old destinations. Curr Biol 9:R864-866
27. Yang Y, Bauer C, Strasser G, Wollman R, Julien JP, Fuchs E (1999) Integrators of the cytoskeleton that stabilize microtubules. Cell 98:229-238
28. Pulkkinen L, Christiano AM, Airenne T, Haakana H, Tryggvason K, Uitto J (1994) Mutations in the gamma 2 chain gene (LAMC2) of kalinin/laminin 5 in the junctional forms of epidermolysis bullosa. Nat Genet 6:293-297
29. Kivirikko S, McGrath JA, Baudoin C, Aberdam D, Ciatti S, Dunnill MG, McMillan JR, Eady RA, Ortonne JP, Meneguzzi G, et al (1995) A homozygous nonsense mutation in the α 3 chain gene of laminin 5 (LAMA3) in lethal (Herlitz) junctional epidermolysis bullosa. Hum Mol Genet 4:959-962
30. Vidal F, Aberdam D, Miquel C, Christiano AM, Pulkkinen L, Uitto J, Ortonne J-P, Meneguzzi G (1995) Integrin β4 mutations associated with junctional epidermolysis bullosa with pyloric atresia. Nat Genet 10:229-234
31. Shimizu H, Suzumori K, Hatta N, Nishikawa T (1996) Absence of detectable α6 integrin in pyloric atresia-junctional epidermolysis bullosa syndrome. Application for prenatal diagnosis in a family at risk for recurrence. Arch Dermatol 132:919-925
32. McGrath JA, Gatalica B, Christiano AM, Li K, Owaribe K, McMillan JR, Eady RA, Uitto J (1995) Mutations in the 180-kD bullous pemphigoid antigen (BPAG2), a hemidesmosomal transmembrane collagen (COL17A1), in generalized atrophic benign epidermolysis bullosa. Nat Genet 11:83-86
33. Fine JD, Horiguchi Y, Couchman JR (1989) 19-DEJ-1, a hemidesmosome-anchoring filament complex-associated monoclonal antibody. Definition of a new skin basement membrane antigenic defect in junctional and dystrophic epidermolysis bullosa. Arch Dermatol 125:520-523
34. Fine JD (1990) 19-DEJ-1, a monoclonal antibody to the hemidesmosome-anchoring filament complex, is the only reliable immunohistochemical probe for all major forms of junctional epidermolysis bullosa. Arch Dermatol 126:1187-1190
35. Fine JD, Holbrook KA, Elias S, Anton Lamprecht I, Rauskolb R (1990) Applicability of 19-DEJ-1 monoclonal antibody for the prenatal diagnosis or exclusion of junctional epidermolysis bullosa. Prenat Diagn 10:219-229
36. Fine JD, Johnson LB, Wright T (1990) Type VII collagen and 19-DEJ-1 antigen. Comparison of expression in inversa and generalized variants of recessive dystrophic epidermolysis bullosa. Arch Dermatol 126:1587-1593
37. Shimizu H, Fine J-D, Suzumori K, Hatta N, Shozu M, Nishikawa T (1994) Prenatal exclusion of pyloric atresia-junctional epidermolysis bullosa syndrome. J Am Acad Dermatol 31:429-433
38. Shimizu H, Suzumori K (1998) Prenatal diagnosis as a test for genodermatoses: its past, present and future. J Dermatol Sci 19: 1-8
39. Heagerty AH, Kennedy AR, Eady RA, Hsi BL, Verrando P, Yeh CJ, Ortonne JP (1986) GB3 monoclonal antibody for diagnosis of junctional epidermolysis bullosa. Lancet 1:860
40. Heagerty AH, Eady RA, Kennedy AR, Nicolaides KH, Rodeck CH, Hsi BL, Ortonne JP (1987) Rapid prenatal diagnosis of epidermolysis bullosa letalis using GB3 monoclonal antibody. Br J Dermatol 117:271-275
41. Schofield OM, Fine JD, Verrando P, Heagerty AH, Ortonne JP, Eady RA (1990) GB3 monoclonal antibody for the diagnosis of junctional epidermolysis bullosa: results of a multicenter study. J Am Acad Dermatol 23:1078-1083
42. Verrando P, Blanchet Bardon C, Pisani A, Thomas L, Cambazard F, Eady RA, Schofield O, Ortonne JP (1991) Monoclonal antibody GB3 defines a widespread defect of several basement membranes and a keratinocyte dysfunction in patients with lethal junctional epidermolysis bullosa. Lab Invest 64:85-92
43. Matsui C, Nelson CF, Hernandez GT, Herron GS, Bauer EA, Hoeffler WK (1995) The gamma 2 chain of laminin-5 is recognised by monoclonal antibody GB3. J Invest Dermatol 105:648-652
44. Jonkman MF, Pas HH, Fine JD (1998) Mosaic expression of uncein, linear IgA bullous dermatosis antigen and 180-kDa bullous pemphigoid antigen in generalized atrophic benign epidermolysis bullosa. Br J Dermatol 138:904
45. Takizawa Y, Shimizu H, Nishizawa T, Hatta N, Pulkkinen L, Uitto J (1997) Novel ITGB4 mutations in a patient with junctional epidermolysis bullosa-pyloric atresia syndrome and altered basement membrane zone immunofluorescence for the α4β4 integrin. J Invest Dermatol 108:943-946
46. Nakano A, Pulkkinen L, Murrell D, Rico J, Lucky AW, Garzon M, Stevens CA, Robertson S, Pfendner E, Uitto J (2001) Epidermolysis bullosa with congenital pyloric atresia: novel mutations in the β4 integrin gene (ITGB4) and genotype/phenotype correlations. Pediatr Res 49:618-626
47. Niessen CM, van der Raaij-Helmer LMH, Hulsman EHM, van der Neut R, Jonkman MF, Sonnenberg A (1996) Deficiency of the integrin β4 in junctional epidermolysis bullosa with pyloric atresia: consequences for hemidesmosome formation and adhesion properties. J Cell Sci 109:1695-1706
48. Virtanen I, Tani T, Back N, Happola O, Laitinen L, Kiviluoto T, Salo J, Burgeson RE, Lehto VP, Kivilaakso E (1995) Differential expression of laminin chains and their integrin receptors in human gastric mucosa. Am J Pathol 147:1123-1132
49. Georges-Labouesse E, Messaddeq N, Yehia G, Cadalbert L, Dierich A, Le Meur M (1996) Absence of integrin alpha 6 leads to epidermolysis bullosa and neonatal death in mice. Nat Genet 13:370-373
50. Nievers MG, Kuikman I, Geerts D, Leigh IM, Sonnenberg A (2000) Formation of hemidesmosome-like structures in the absence of ligand binding by the (alpha)6(beta)4 integrin requires binding of HD1/plectin to the cytoplasmic domain of the (beta)4 integrin subunit. J Cell Sci 113:963-973
51. Christiano AM, Rosenbaum LM, Chung Honet LC, Parente MG, Woodley DT, Pan TC, Zhang RZ, Chu ML, Burgeson RE, Uitto J (1992) The large non-collagenous domain (NC-1) of type VII collagen is amino-terminal and chimeric. Homology to cartilage matrix protein, the type III domains of fibronectin and the A domains of von Willebrand factor. Hum Mol Genet 1:475-481
52. Bruckner-Tuderman L, Hopfner B, Hammami-Hauasli N (1999) Biology of anchoring fibrils: lessons from dystrophic epidermolysis bullosa. Matrix Biol 18:43-54
53. Shimizu H, Hammami-Hauasli N, Hatta N, Nishikawa T, Bruckner-Tuderman L (1999) Compound heterozygosity for silent and dominant glycine substitution mutations in COL7A1 leads to a marked transient intracytoplasmic retention of procollagen VII and moderately severe dystrophic epidermolysis bullosa phenotype. J Invest Dermatol 113:419-421
54. Dharma B, Moss C, McGrath JA, Mellerio JE, Ilchyshyn A (2001) Dominant dystrophic epidermolysis bullosa presenting as familial nail dystrophy. Clin Exp Dermatol 26:93-96
55. Sato-Matsumura KC, Yasukawa K, Tomita Y, Shimizu H (2002) Toenail dystrophy with COL7A1 glycine substitution mutations segregates as an autosomal dominant trait in two families with dystrophic epidermolysis bullosa. Arch Dermatol 138:269-270
56. Keene DR, Sakai LY, Lunstrum GP, Morris NP, Burgeson RE (1987) Type VII collagen forms an extended network of anchoring fibrils. J Cell Biol 104:611-621
57. Sakai LY, Keene DR, Morris NP, Burgeson RE (1986) Type VII collagen is a major structural component of anchoring fibrils. J Cell Biol 103:1577-1580
58. Burgeson RE, Morris NP, Murray LW, Duncan KG, Keene DR, Sakai LY (1985) The structure of type VII collagen. Ann N Y Acad Sci 469:47-57
59. Shimizu H, Ishiko A, Masunaga T, Kurihara Y, Sato M, Bruckner-Tuderman L, Nishikawa T (1997) Most anchoring fibrils in human skin originate and terminate in the lamina densa. Lab Invest 76:753-763
60. Jassim A, Schofield O, Whitehead P, Purkis P, Heagerty AH, Sachs JA, Eady RA, Leigh IM (1991) Detection of a novel basement membrane antigen by GDA-J/F3 anti-human sperm fibrous sheath monoclonal antibody. Br J Dermatol 125:101-107
61. McGrath JA, Schofield OM, Mayou BJ, McKee PH, Eady RA (1992) Epidermolysis bullosa complicated by squamous cell carcinoma: report of 10 cases. J Cutan Pathol 19:116-123
62. Kawasaki H, Sawamura D, Iwao F, Kikuchi T, Nakamura H, Okubo S, Matsumura T, Shimizu H (2003) Squamous cell carcinoma developed in a 12-year-old boy with non-Hallopeau-Siemens recessive dystrophic epidermolysis bullosa. Br J Dermatol (in press)
63. Weber F, Bauer JW, Sepp N, Hogler W, Salmhofer W, Hintner H, Fritsch P (2001) Squamous cell carcinoma in junctional and dystrophic epidermolysis bullosa. Acta Derm Venereol 81:189-192
64. Chopra V, Tyring SK, Johnson L, Fine JD (1990) Patients with severe forms of inherited epidermolysis bullosa exhibit decreased lymphokine and monokine production. J Clin Immunol 10:321-329
65. McGrath JA, Handyside AH (1998) Preimplantation genetic diagnosis of severe inherited skin diseases. Exp Dermatol 7: 65-72
66. Cserhalmi-Friedman PB, Tang Y, Adler A, Krey L, Grifo JA, Christiano AM (2000) Preimplantation genetic diagnosis in two families at risk for recurrence of Herlitz junctional epidermolysis bullosa. Exp Dermatol 9:290-297
67. Takabayashi H, Kuwabara S, Ukita T, Ikawa K, Yamafuji K, Igarashi T (1995) Development of non-invasive fetal DNA diagnosis from maternal blood. Prenat Diagn 15:74-77
68. Rheinwald JG, Green H (1975) Serial cultivation of strains of human epidermal keratinocytes; the formation of keratinizing colonies from single cells. Cell 6:331-343
69. Martinez Pardo ME, Reyes Frias ML, Ramos Duron LE, Gutierrez Salgado E, Gomez JC, Marin MA, Luna Zaragoza D (1999) Clinical application of amniotic membranes on a patient with epidermolysis bullosa. Ann Transplant 4:68-73
70. Rochat A, Kobayashi K, Barrandon Y (1994) Location of stem cells of human hair follicles by clonal analysis. Cell 76:1063-1073
71. Akiyama M, Dale BA, Sun TT, Holbrook KA (1995) Characterization of hair follicle bulge in human fetal skin: the human fetal bulge is a pool of undifferentiated keratinocytes. J Invest Dermatol 105 :844-850
72. Cao T, Longley MA, Wang XJ, Roop DR (2001) An inducible mouse model for epidermolysis bullosa simplex: implications for gene therapy. J Cell Biol 52:651-656
73. Arin MJ, Longley MA, Wang XJ, Roop DR (2001) Focal activation of a mutant allele defines the role of stem cells in mosaic skin disorders J Cell Biol 152:645-649
74. Dellambra E, Pellegrini G, Guerra L, Ferrari G, Zambruno G, Mavilio F, De Luca M (2000) Toward epidermal stem cell-mediated ex vivo gene therapy of junctional epidermolysis bullosa. Hum Gene Ther 11:2283-2287
75. Sawamura D, Meng X, Ina S, Nakano H, Tamai K, Nomura K, Hanada K, Miyazaki J, Hashimoto I (1999) Promoter/enhancer cassettes for keratinocyte gene therapy. J Invest Dermatol 112: 829-830
76. Woodley D, Chen M, Krueger K, Jorgensen C, Chan L, Fairley J (2001) Dermal fibroblasts alone are capable of producing type VII (anchoring fibril) collagen at the dermo-epidermal junction (abstract). J Invest Dermatol 117:399
77. Hengge UR, Chan EF, Foster RA, Walker PS, Vogel JC (1995) Cytokine gene expression in epidermis with biological effects following injection of naked DNA. Nat Genet 10:161-166
78. Sawamura D, Meng X, Ina S, Ishikawa H, Tamai K, Nomura K, Hanada K, Hashimoto I, Kaneda Y (1997) In vivo transfer of a foreign gene to keratinocytes using the hemagglutinating virus of Japan-liposome method. J Invest Dermatol 108:195-199
79. Sawamura D, Meng X, Ina S, Sato M, Tamai K, Hanada K, Hashimoto I (1998) Induction of keratinocyte proliferation and lymphocyte infiltration by in vivo introduction of the IL-6 gene into keratinocytes and possibility of keratinocyte gene therapy for inflammatory skin diseases using IL-6 mutant genes. J Immunol 161:5633-5639
80. Sawamura D, Yasukawa K, Kodama K, Yokota K, Sato-Matsumura KC, Toshihiro T, Shimizu H (2002) The majority of keratinocytes incorporate intradermally injected plasmid DNA regardless of size but only a small proportion of cells can express the gene product. J Invest Dermatol 118:967-971
81. Baumqartner I, Pieczek A, Manor O, et al (1998) Constitutive expression of phVEGF 15 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia. Circulation 97:1114-1123